Sep 6, 2016 — Target Company is a biotech company that has developed a sub-micron delivery technology for both small and large molecules. The company has already applied its delivery system to nutraceutical products and produces and distributes innovative and healthy nutraceuticals that are based on natural therapies and absorbed naturally by the body. It's a R&D organization. They utilize state-of-the-art nanotechnologies to deliver healthy alternatives to conventional pharmaceuticals that all-too-often create dangerous side-effects and unexpected consequences for those trying to attain and maintain healthy lives. Their research and development scientists have more than 60 years of combined experience and are dedicated to providing the best nutraceutical products for natural comfort, health, and their well-being.
Diabetes is a chronic disease that affects not only the health of people living with diabetes, but also imposes significant direct and indirect costs on them and on society as a whole. These costs have escalated sharply over the last decade and are expected to continue their rapid ascent for the foreseeable future. It is a personal crisis for people living with the disease, and for their family. It is also a financial crisis for their healthcare system. It is consuming an ever-larger share of provincial and territorial healthcare budgets, and will force an increase in those expenditures.
Company is concentrating on altering the delivery ways for well-known drugs, currently administered only by injections, to non-invasive (oral or sublingual) routes. The Company is in the early stages of research with respect to all of its technologies.
The intraoral insulin tablet is targeted towards patients with Type 2 diabetes as well as patients with pre-diabetes. These populations represent the largest segment of the global diabetic population (387 million people) with expected worldwide rising disease prevalence to 592 million by 2035. An analysis of these conditions has shed light on pre-diabetes, encouraging early detection and early treatment of the disease. It is predicted that early administration of insulin to pre-diabetics and type 2 diabetic patients would not only help to control blood glucose but also may significantly decelerate disease progression. Fear of needles and lack of a convenient non-invasive dosage form for insulin delivery may be the main reasons against wide use and early start of insulin administration.
Company is looking to raise $10mn in Convertible Preferred Shares.
Company is listed on Nasdaq Pink Sheets. Management has around 80% of the shares.
Conservative projections of taking only 0.25% of target market share (Malaysia, Mexico and Canada) will result with more than 100% ROI for the investor as at Dec 2019.
Year Revenue EBITA
2015 134,000 -4m
2016 3.4m -3m
2017 21m 2.5m
2018 83m 38m
2019 172m 88.4m
More Deals Like This One
Apr 23, 2018 — National medical service provider based in the Pacific Northwest, established in 1998. The company services a particular niche in their industry that is 100% commercial sales. All clients are on contract, but contracts are predominately short term. There are opportunities to negotiate longer term contracts...
May 2, 2018 — Own a new franchise in Seattle for a national health improvement and weight loss company. Patented method of hunger control provides extraordinary results. Developed by a physician who combined all-natural disciplines into a comprehensive program for patients to lose weight, maintain weight loss & improve...
Apr 3, 2018 — This retail optical boutique is located in a quaint, stand-alone building in Idaho. The state has seen an influx of families moving from states all around the US looking for a simpler and more fulfilling life, which has led to an economic boom, especially in the downtown areas. This well-established...
Apr 24, 2018 — Own a new franchise in Minneapolis for a national health improvement and weight loss company. Patented method of hunger control provides extraordinary results. Developed by a physician who combined all-natural disciplines into a comprehensive program for patients to lose weight, maintain weight loss...
Aug 19, 2017 — This company provides room, board, and 24 hour care for adults with developmental disabilities, which include: tramatic brain injury, MI, DD, & E/CD. The experienced, trained, and caring staff is the best in the industry. There are eight individual locations. Each location is at maximum capacity...